1 dataset found
Dataset from A Phase 2 Multicenter Study of the Safety and Efficacy of...
- data.niaid.nih.gov
Updated Feb 22, 2025
Share
Facebook
Twitter
EmailClick to copy linkLink copiedCiteMartin Okun, MD, PhD (2025). Dataset from A Phase 2 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa [Dataset]. http://doi.org/10.25934/00003054Unique identifierhttps://doi.org/10.25934/00003054Dataset updatedFeb 22, 2025AuthorsMartin Okun, MD, PhDArea coveredDenmark, Germany, Netherlands, United StatesVariables measuredSkin Plaque, Inflammation, Hidradenitis Suppurativa, Physician's Global EvaluationDescriptionThis study will investigate how well adalimumab works in people with hidradenitis suppurativa (HS) in the short and long term.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
Share
FacebookTwitterEmailClick to copy link
Link copied
Cite
Martin Okun, MD, PhD (2025). Dataset from A Phase 2 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa [Dataset]. http://doi.org/10.25934/00003054
Dataset from A Phase 2 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa
Unique identifier
https://doi.org/10.25934/00003054Dataset updated
Feb 22, 2025Authors
Martin Okun, MD, PhD Area covered
Denmark, Germany, Netherlands, United StatesVariables measured
Skin Plaque, Inflammation, Hidradenitis Suppurativa, Physician's Global EvaluationDescription
This study will investigate how well adalimumab works in people with hidradenitis suppurativa (HS) in the short and long term.